Form D · Biotechnology
Aidia Investment Group, Inc.
Research Triangle Park, NC · CIK 0001726298
Offering snapshot reported Dec 26, 2017 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 11, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 26, 2017 | Initial | $500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-301611
Source: Form D, filed Dec 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Catherine Arrington | Executive |
| Chamroen Chetty | Director, Executive |
| Bela Horvath | Director |
| Jinjie Hu | Director |
| Gary Mills | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
104 Tw Alexander Drive
Research Triangle Park, NC, 27709
Research Triangle Park, NC, 27709